Vimarsana
Biggest News Aggregation in the World

Page 9 - Bardy Diagnostics News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Bardy Diagnostics. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Bardy Diagnostics Today - Breaking & Trending Today

Cardiac wearables, iRhythm, under a cloud as reimbursement questions linger - Vimarsana News

Cardiac wearables, iRhythm, under a cloud as reimbursement questions linger

Share it While attention focused on iRhythm Technologies after Medicare rates for long-term cardiac monitoring were slashed in January, the fallout is now extending to other players and the future of the much-hyped market is being questioned. Novitas Solutions, which sets regional Medicare rates as a Medicare Administrative Contractor, is working with iRhythm and rivals about possibly changing the published rates. However, there is no timetable for when — or if — the rates will change, leaving Wall Street and industry in a holding pattern. Baird Equity Research analyst Mike Polark said t...

H|T: The Healthtech Times - Subscription prescription - Vimarsana News

H|T: The Healthtech Times - Subscription prescription

H|T: The Healthtech Times H|T: The Healthtech Times – Subscription prescription The Healthtech Times is a weekly newsletter covering healthtech news from Canada and around the globe. Subscribe to H|T using the form at the bottom of this page to ensure you don’t miss out on the most important healthtech news every week!

Hillrom faces lawsuit after dropping planned $375M Bardy Diagnostics deal - Vimarsana News

Hillrom faces lawsuit after dropping planned $375M Bardy Diagnostics deal

Hillrom axed plans to acquire cardiac monitoring company Bardy Diagnostics over reimbursement changes by a Medicare contractor. Bardy filed suit against Hillrom on Sunday.

Hillrom's retreat from $375M Bardy Diagnostics acquisition countered in court - Vimarsana News

Hillrom's retreat from $375M Bardy Diagnostics acquisition countered in court

Share A January acquisition deal between medical technology provider Hillrom and cardiac monitoring device maker Bardy Diagnostics has landed in rocky waters, with Hillrom looking to back out of the purchase and Bardy filing a legal complaint to keep things moving forward. According to press releases from Hillrom, the company was caught off guard on January 29 when Novitas Solutions, a Medicare Administrative Contractor (MAC), published reimbursement rates for relevant CPT codes that were well below its expectations. Hillrom said the rate reduction meets the criteria of a "Company Materi...

Hillrom Provides Update on Planned Acquisition of Bardy Diagnostics, Inc. - Vimarsana News

Hillrom Provides Update on Planned Acquisition of Bardy Diagnostics, Inc.

Share: CHICAGO, March 1, 2021 /PRNewswire/ -- Hillrom (NYSE:HRC) today provided an update on its planned acquisition of Bardy Diagnostics, Inc. (BardyDx), which it previously announced on January 19, 2021.  On January 29, 2021, a Medicare Administrative Contractor, Novitas Solutions, published new Category 1 reimbursement rates applicable to the Current Procedural Terminology (CPT) codes for the long-term cardiac monitoring category, including CPT codes 93241, 93243, 93245 and 93247. As a result of the unexpected Novitas reimbursement rate reduction, Hillrom has asserted that a "Company Ma...